These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9403601)

  • 1. Transition from hypertrophy to failure.
    Lorell BH
    Circulation; 1997 Dec; 96(11):3824-7. PubMed ID: 9403601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular pathogenesis of heart failure].
    Maier LS
    Dtsch Med Wochenschr; 2006 Mar; 131(10):503-5. PubMed ID: 16511741
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physiopathology of heart failure and new approach to the therapy].
    Yazaki Y
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1449-53. PubMed ID: 8537748
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACE-inhibitors, AT1 receptor antagonists and diastolic dysfunction].
    Metra M; Nodari S; Bordonali T; Cagnazzi E; Boldi E; Dei Cas L
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):53-8. PubMed ID: 12497882
    [No Abstract]   [Full Text] [Related]  

  • 5. Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats.
    Meurrens K; Ruf S; Ross G; Schleef R; von Holt K; Schlüter KD
    Cardiovasc Res; 2007 Nov; 76(2):311-22. PubMed ID: 17658497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional consequence of serotonin/5-HT2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure?
    Nebigil CG; Maroteaux L
    Circulation; 2003 Aug; 108(7):902-8. PubMed ID: 12925446
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progress in the treatment of cardiac insufficiency].
    Perrenoud JJ
    Rev Med Suisse Romande; 1998 Jul; 118(7):625-30. PubMed ID: 9708019
    [No Abstract]   [Full Text] [Related]  

  • 10. Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats.
    Ikeda S; Hamada M; Hiwada K
    Clin Sci (Lond); 1999 Aug; 97(2):239-46. PubMed ID: 10409480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial hypertrophy and heart failure: a complex relationship].
    Barsotti A; Dini FL
    Cardiologia; 1993 Mar; 38(3):191-205. PubMed ID: 8339309
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload.
    Bing OH
    J Mol Cell Cardiol; 1994 Aug; 26(8):943-8. PubMed ID: 7799449
    [No Abstract]   [Full Text] [Related]  

  • 14. Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy.
    Cingolani HE; Ennis IL
    Circulation; 2007 Mar; 115(9):1090-100. PubMed ID: 17339567
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac calcineurin during transition from hypertrophy to heart failure in rats.
    Hayashida W; Kihara Y; Yasaka A; Sasayama S
    Biochem Biophys Res Commun; 2000 Jun; 273(1):347-51. PubMed ID: 10873609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
    Ziegelhöffer-Mihalovicova B; Arnold N; Marx G; Tannapfel A; Zimmer HG; Rassler B
    Life Sci; 2006 Jul; 79(9):838-46. PubMed ID: 16624325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
    McMullen JR; Jennings GL
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):255-62. PubMed ID: 17324134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K; Ferro A
    Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNAs in hypertrophy and heart failure.
    Latronico MV; Condorelli G
    Exp Biol Med (Maywood); 2011 Feb; 236(2):125-31. PubMed ID: 21321308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.